Registry of Lobbyists
Total Number of Communication Reports: 8
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Health
|
Engagement with officials on Bill S-280, An Act respecting a national framework on sickle cell disease, to discuss measures and initiatives to improve care and treatment of Canadians affected by sickle cell disease and increase public awareness of the disease.
|
Legislative Proposal, Bill or Resolution
|
|
Health
|
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
|
Policies or Program
|
|
Budget, Health
|
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals.
|
Policies or Program
|
|
Health
|
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
|
Policies or Program, Regulation
|
|
Health, Industry
|
Innovation, Science and Economic Development Canada and Innovation Agenda, Science and Technology Strategy, or other Government policy or program initiatives to support research and development activities in Canada.
|
Policies or Program
|
|
Health
|
Proposals to amend guidelines related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board
|
Policies or Program
|
|
Health
|
Regulatory amendments and/or guidelines related to the Food and Drugs Act Regulations and Health Canada review processes to implement an orphan drug regulatory framework.
|
Regulation, Policies or Program
|
|
Health
|
The development of a national pharmacare program, including Canada's Drug Agency, a national formulary and a rare diseases strategy
|
Policies or Program
|
Address:
20 Bay Street
Suite 1520
Toronto, ON M5J 2N8
Canada
Telephone number:
647-790-1602
Web address:
www.vrtx.com
Christina Cunningham, Director of Public Affairs - Canada
Vertex Pharmaceuticals (Canada) Inc. is not a coalition.
The activities of Vertex Pharmaceuticals (Canada) Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Vertex Pharmaceuticals (Canada) Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
WILLIAM DEMPSTER | Public offices held
Firm: 3Sixty Public Affairs Inc. / 3Sixty Public Affairs Inc.